Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Markets & Finance

Goldman Adds Alcon to 'Recommended List'

Goldman Sachs added Alcon (ACL) to its recommended list; the stock was previously rated market outperform.

Analyst Katherine Breeds says Alcon represents an attractive investment opportunity. She notes the company earns strong marks when assessed on a relative basis to other specialty pharmaceutical companies in her universe based on industry metrics, value creation and earnings per share quality.

She raised her $1.55 2002 earnings per share estimate to $1.56, and upped the $1.71 2003 earnings per share estimate to $1.79.

The Aging of Abercrombie & Fitch
blog comments powered by Disqus